These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1665354)

  • 21.
    Dedı Ková A; Bárta F; Martínek V; Kotalík K; Dušková Š; Mráz J; Arlt VM; Stiborová M; Hodek P
    Chem Res Toxicol; 2020 Nov; 33(11):2804-2818. PubMed ID: 32894017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formation and persistence of specific purine DNA adducts by 32P-postlabelling in target and non-target organs of rats treated with aristolochic acid I.
    Fernando RC; Schmeiser HH; Scherf HR; Wiessler M
    IARC Sci Publ; 1993; (124):167-71. PubMed ID: 8225480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the mutagenicity of aristolochic acid I and aristolochic acid II in the gpt delta transgenic mouse kidney.
    Xing G; Qi X; Chen M; Wu Y; Yao J; Gong L; Nohmi T; Luan Y; Ren J
    Mutat Res; 2012 Mar; 743(1-2):52-8. PubMed ID: 22245565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liquid chromatography-tandem mass spectrometry analysis of the DNA adducts of aristolochic acids.
    Chan W; Zheng Y; Cai Z
    J Am Soc Mass Spectrom; 2007 Apr; 18(4):642-50. PubMed ID: 17208007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noninvasive measurement of aristolochic acid-DNA adducts in urine samples from aristolochic acid-treated rats by liquid chromatography coupled tandem mass spectrometry: evidence for DNA repair by nucleotide-excision repair mechanisms.
    Leung EM; Chan W
    Mutat Res; 2014; 766-767():1-6. PubMed ID: 25847264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the metabolism of aristolochic acids I and II.
    Krumbiegel G; Hallensleben J; Mennicke WH; Rittmann N; Roth HJ
    Xenobiotica; 1987 Aug; 17(8):981-91. PubMed ID: 3673113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The binding of aristolochic acid I to the active site of human cytochromes P450 1A1 and 1A2 explains their potential to reductively activate this human carcinogen.
    Stiborová M; Sopko B; Hodek P; Frei E; Schmeiser HH; Hudecek J
    Cancer Lett; 2005 Nov; 229(2):193-204. PubMed ID: 16125300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of the carcinogen-DNA adducts formed in rat liver in vivo after administration of single or multiple doses of N-methyl-4-aminoazobenzene.
    Tillis DL; Straub KM; Kadlubar FF
    Chem Biol Interact; 1981 Dec; 38(1):15-27. PubMed ID: 7326805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benzenediazonium ion derived from Sudan I forms an 8-(phenylazo)guanine adduct in DNA.
    Stiborová M; Asfaw B; Frei E; Schmeiser HH; Wiessler M
    Chem Res Toxicol; 1995 Jun; 8(4):489-98. PubMed ID: 7548728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reaction of epichlorohydrin with adenosine, 2'-deoxyadenosine and calf thymus DNA: identification of adducts.
    Sund P; Kronberg L
    Bioorg Chem; 2006 Jun; 34(3):115-30. PubMed ID: 16549090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and mutagenicity of metabolites of aristolochic acid formed by rat liver.
    Schmeiser HH; Pool BL; Wiessler M
    Carcinogenesis; 1986 Jan; 7(1):59-63. PubMed ID: 3510750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and characterization of the major DNA adduct formed chemically and in vitro from the environmental genotoxin 3-nitrofluoranthene.
    Dietrich AM; Guenat CR; Tomer KB; Ball LM
    Carcinogenesis; 1988 Nov; 9(11):2113-9. PubMed ID: 3180346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of adducts formed in the reaction of glutaraldehyde with 2'-deoxyadenosine.
    Olsen R; Backman J; Molander P; Øvrebø S; Thorud S; Lundanes E; Greibrokk T; Kronberg L
    Chem Res Toxicol; 2007 Jun; 20(6):965-74. PubMed ID: 17518482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved preparation and identification of aristolochic acid-DNA adducts by solid-phase extraction with liquid chromatography-tandem mass spectrometry.
    Gao H; Guo F; Feng F; Yin J; Song M; Wang H
    J Environ Sci (China); 2009; 21(12):1769-76. PubMed ID: 20131611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a reduction product of aristolochic acid: implications for the metabolic activation of carcinogenic aristolochic acid.
    Priestap HA; de los Santos C; Quirke JM
    J Nat Prod; 2010 Dec; 73(12):1979-86. PubMed ID: 21141875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues.
    Schmeiser HH; Janssen JW; Lyons J; Scherf HR; Pfau W; Buchmann A; Bartram CR; Wiessler M
    Cancer Res; 1990 Sep; 50(17):5464-9. PubMed ID: 2201437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitroreduction of 4-nitropyrene is primarily responsible for DNA adduct formation in the mammary gland of female CD rats.
    Chae YH; Ji BY; Lin JM; Fu PP; Cho BP; El-Bayoumy K
    Chem Res Toxicol; 1999 Feb; 12(2):180-6. PubMed ID: 10027796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formation of acrolein adducts with 2'-deoxyadenosine in calf thymus DNA.
    Pawłowicz AJ; Munter T; Zhao Y; Kronberg L
    Chem Res Toxicol; 2006 Apr; 19(4):571-6. PubMed ID: 16608169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of C8-modified deoxyinosine and N2- and C8-modified deoxyguanosine as major products of the in vitro reaction of N-hydroxy-6-aminochrysene with DNA and the formation of these adducts in isolated rat hepatocytes treated with 6-nitrochrysene and 6-aminochrysene.
    Delclos KB; Miller DW; Lay JO; Casciano DA; Walker RP; Fu PP; Kadlubar FF
    Carcinogenesis; 1987 Nov; 8(11):1703-9. PubMed ID: 3664962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of cytochromes P450 in metabolism of carcinogenic aristolochic acid I: evidence of their contribution to aristolochic acid I detoxication and activation in rat liver.
    Stiborova M; Mares J; Levova K; Pavlickova J; Barta F; Hodek P; Frei E; Schmeiser HH
    Neuro Endocrinol Lett; 2011; 32 Suppl 1():121-30. PubMed ID: 22167220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.